Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
Appointed director
Inmune Bio, Inc. (INMB) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2023 8-K Quarterly results
Docs: "INMUNE BIO INC. CONSOLIDATED BALANCE SHEETS"
05/04/2023 8-K Quarterly results
Docs: "PRESS RELEASE FOR FINANCIAL RESULTS AND BUSINESS UPDATE"
11/02/2022 8-K Quarterly results
08/03/2022 8-K Quarterly results
05/06/2022 8-K Quarterly results
11/04/2021 8-K Quarterly results
Docs: "PRESS RELEASE FOR FINANCIAL RESULTS AND BUSINESS UPDATE"
08/05/2021 8-K Quarterly results
Docs: "INmune Bio, Inc. Announces Second Quarter 2021 Results and Provides Business Update",
"Investor Contact: Chuck Padala LifeSci Advisors 627-8390"
05/06/2021 8-K Quarterly results
11/06/2020 8-K Quarterly results
Docs: "Q3 2020 and Recent Corporate Highlights DN-TNF Platform Highlights: ● Announced interim Phase Ib data demonstrating that over a 12-week period, XPro1595 decreased neuroinflammation by 40.6% in the arcuate fasciculus, a white matter pathway important for learning and memory in patients with Alzheimer’ s disease. The 13 July KOL webinar discussing the data can be found by https://inmunebio.com/index.php/en/science/xpro1595/videos. ● Awarded a National Institutes of Health Small Business Innovation Research Grant of up to $2.9 million to support a phase 2 study of XPro1595 in patients with treatment resistant depression . The study, entitled, “Effects of the Next Generation TNF Inhibitor on Inflammation-related Deficits in Reward Circuitry and Motivation in Depression,” will be co..."
08/06/2020 8-K Quarterly results
05/15/2020 8-K Quarterly results
Docs: "CONSOLIDATED BALANCE SHEETS"
03/12/2020 8-K Quarterly results
11/12/2019 8-K Quarterly results
08/13/2019 8-K Quarterly results
05/16/2019 8-K Quarterly results
Docs: "Purchase Agreement between INmune Bio Inc. and Lincoln Park Capital Fund, LLC",
"Registration Rights Agreement between INmune Bio Inc. and Lincoln Park Capital Fund, LLC",
"INmune Bio Reports First Quarter 2019 Financial Results and Provides Shareholder Update GlobeNewswire",
"INmune Bio, Inc."

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy